330
Participants
Start Date
June 30, 2016
Primary Completion Date
March 31, 2020
Study Completion Date
June 11, 2020
Tranexamic Acid
Doses will be given intravenous (IV) or orally (PO) per the discretion of the treating investigator. Doses are administered every 8 hours. When given IV, TXA 1.0 gram will be administered. When given PO, TXA 1.3 grams will be administered
Placebo
Doses will be given intravenous (IV) or orally (PO) per the discretion of the treating investigator. Doses are administered every 8 hours. When given IV, Normal Saline will be administered. When given PO, placebo pills will be administered
University of Pittsburgh, Pittsburgh
University of North Carolina, Chapel Hill
University of Washington, Seattle
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Washington
OTHER